Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035309931> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2035309931 endingPage "369" @default.
- W2035309931 startingPage "367" @default.
- W2035309931 abstract "The potency of mioflazine and related drugs (Janssen Pharmaceutica, Belgium) as inhibitors of adenosine transport in isolated erythrocytes from several species were measured and compared with those of dilazep and 6-(4-nitrobenzylmercapto)purine ribonucleoside (NBMPR). [8-3H]Adenosine was used as the permeant at 1 microM and incubation times were 10 s, and assays were conducted in the presence and absence of varying doses of potential transport inhibitors. The species investigated included mouse, hamster, rabbit, baboon and man. Dilazep was the most potent compound throughout with an IC50 of about 2 nM. In the mouse and hamster mioflazine and its derivatives were considerably less potent (IC50 values greater than 200 nM) with the exception of R57974 with IC50 values of about 150 and 60 nM in mouse and hamster, respectively. In the man and baboon the derivatives had IC50 values in the same order of magnitude as NBMPR (less than 100 nM), and in the rabbit they had potencies close to that of NBMPR, ranging between 10-60 nM. Nucleoside transport inhibitors are of potential importance as host protectors during treatment of parasitic infections with cytotoxic nucleosides. Present data indicate that mioflazine and its derivatives are not very potent in some of the preferred animal models for parasitic infections (mouse, hamster) but are more effective in primates such as man and baboon." @default.
- W2035309931 created "2016-06-24" @default.
- W2035309931 creator A5028402226 @default.
- W2035309931 creator A5061660231 @default.
- W2035309931 creator A5062929814 @default.
- W2035309931 creator A5074369451 @default.
- W2035309931 creator A5078862024 @default.
- W2035309931 date "1990-05-01" @default.
- W2035309931 modified "2023-09-27" @default.
- W2035309931 title "Potencies of mioflazine and its derivatives as inhibitors of adenosine transport in isolated erythrocytes from different species" @default.
- W2035309931 cites W1642115037 @default.
- W2035309931 cites W1976218679 @default.
- W2035309931 cites W1983959416 @default.
- W2035309931 cites W1991871309 @default.
- W2035309931 cites W2043796390 @default.
- W2035309931 cites W2060876849 @default.
- W2035309931 cites W2141773320 @default.
- W2035309931 cites W2246661972 @default.
- W2035309931 cites W2487006092 @default.
- W2035309931 cites W2611978234 @default.
- W2035309931 cites W62528477 @default.
- W2035309931 doi "https://doi.org/10.1111/j.2042-7158.1990.tb05432.x" @default.
- W2035309931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1976791" @default.
- W2035309931 hasPublicationYear "1990" @default.
- W2035309931 type Work @default.
- W2035309931 sameAs 2035309931 @default.
- W2035309931 citedByCount "14" @default.
- W2035309931 crossrefType "journal-article" @default.
- W2035309931 hasAuthorship W2035309931A5028402226 @default.
- W2035309931 hasAuthorship W2035309931A5061660231 @default.
- W2035309931 hasAuthorship W2035309931A5062929814 @default.
- W2035309931 hasAuthorship W2035309931A5074369451 @default.
- W2035309931 hasAuthorship W2035309931A5078862024 @default.
- W2035309931 hasConcept C134018914 @default.
- W2035309931 hasConcept C153911025 @default.
- W2035309931 hasConcept C181199279 @default.
- W2035309931 hasConcept C185592680 @default.
- W2035309931 hasConcept C202751555 @default.
- W2035309931 hasConcept C2776476023 @default.
- W2035309931 hasConcept C2776543447 @default.
- W2035309931 hasConcept C2776991684 @default.
- W2035309931 hasConcept C2777752497 @default.
- W2035309931 hasConcept C2777755551 @default.
- W2035309931 hasConcept C2778575167 @default.
- W2035309931 hasConcept C2779594886 @default.
- W2035309931 hasConcept C55493867 @default.
- W2035309931 hasConcept C57992300 @default.
- W2035309931 hasConcept C86803240 @default.
- W2035309931 hasConcept C98274493 @default.
- W2035309931 hasConceptScore W2035309931C134018914 @default.
- W2035309931 hasConceptScore W2035309931C153911025 @default.
- W2035309931 hasConceptScore W2035309931C181199279 @default.
- W2035309931 hasConceptScore W2035309931C185592680 @default.
- W2035309931 hasConceptScore W2035309931C202751555 @default.
- W2035309931 hasConceptScore W2035309931C2776476023 @default.
- W2035309931 hasConceptScore W2035309931C2776543447 @default.
- W2035309931 hasConceptScore W2035309931C2776991684 @default.
- W2035309931 hasConceptScore W2035309931C2777752497 @default.
- W2035309931 hasConceptScore W2035309931C2777755551 @default.
- W2035309931 hasConceptScore W2035309931C2778575167 @default.
- W2035309931 hasConceptScore W2035309931C2779594886 @default.
- W2035309931 hasConceptScore W2035309931C55493867 @default.
- W2035309931 hasConceptScore W2035309931C57992300 @default.
- W2035309931 hasConceptScore W2035309931C86803240 @default.
- W2035309931 hasConceptScore W2035309931C98274493 @default.
- W2035309931 hasIssue "5" @default.
- W2035309931 hasLocation W20353099311 @default.
- W2035309931 hasLocation W20353099312 @default.
- W2035309931 hasOpenAccess W2035309931 @default.
- W2035309931 hasPrimaryLocation W20353099311 @default.
- W2035309931 hasRelatedWork W1504841080 @default.
- W2035309931 hasRelatedWork W1979455759 @default.
- W2035309931 hasRelatedWork W2016866166 @default.
- W2035309931 hasRelatedWork W2035309931 @default.
- W2035309931 hasRelatedWork W2060374096 @default.
- W2035309931 hasRelatedWork W2060502221 @default.
- W2035309931 hasRelatedWork W2087917378 @default.
- W2035309931 hasRelatedWork W2093311912 @default.
- W2035309931 hasRelatedWork W2095528918 @default.
- W2035309931 hasRelatedWork W2343477184 @default.
- W2035309931 hasVolume "42" @default.
- W2035309931 isParatext "false" @default.
- W2035309931 isRetracted "false" @default.
- W2035309931 magId "2035309931" @default.
- W2035309931 workType "article" @default.